Amyotrophic lateral sclerosis, also referred to as Lou Gehrig's Disease is a neurological disease that affects nerve cells in the spinal cord and brain. In Amyotrophic lateral sclerosis, the motor neurons die and the ability of the brain to control muscle movement is lost. This leads to muscle weakness and eventually death. The leading cause of Amyotrophic lateral sclerosis is a hereditary mutation on chromosome 21. There is no known cure for Amyotrophic lateral sclerosis; however, the drug Riluzole has been proven to delay the onset of tracheostomy and increase survival by approximately 3-5 months.
Amyotrophic Lateral Sclerosis Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Amyotrophic Lateral Sclerosis below!
For more information on how to use Laverne, please read the How to Guide.
We have 2089 products for the study of Amyotrophic Lateral Sclerosis that can be applied to Western Blot, Chromatin Immunoprecipitation, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.
Amyotrophic Lateral Sclerosis is also known as amyotrophic lateral sclerosis, als, motor neuron disease, amyotrophic lateral sclerosis, amyotrophic lateral sclerosis (disorder), charcot disease, dementia with amyotrophic lateral sclerosis, familial amyotrophic lateral sclerosis, amyotrophic lateral sclerosis type 1, amyotrophic lateral sclerosis 1, motor neuron disease, bulbar, motor neuron disease, dementia, als1, fals.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.